Webcast / Audiocast

0 Comments

9 December 2016

LEADERS-FREE

Keith Oldroyd

Biosensors drug coated stent vs BMS

Video and Audio streaming
MP3 podcast available for download

Previous | Next

Summary

LEADERS-FREE, a randomised double-blinded trial published in the New England Journal of Medicine (NEJM LEADERS FREE). The trial was designed to assess the combination of a short course (1 month) of DAPT with either the BioFreedom drug coated stent or the Gazelle BMS in patients with a high risk of bleeding.

  • Oral anticoagulant treatment
  • Elderly ≥ 75
  • Anaemia
  • Low platelet count
  • Previous bleeding
  • Co-morbid disease (eg chronic renal failure or cancer)

Here Keith Oldroyd presents the results of LEADERS-FREE and how this may change the way we treat high risk population who often have the most to gain from revascularisation.

 

Summary

LEADERS-FREE, a randomised double-blinded trial published in the New England Journal of Medicine (NEJM LEADERS FREE). The trial was designed to assess the combination of a short course (1 month) of DAPT with either the BioFreedom drug coated stent or the Gazelle BMS in patients with a high risk of bleeding.

  • Oral anticoagulant treatment
  • Elderly ≥ 75
  • Anaemia
  • Low platelet count
  • Previous bleeding
  • Co-morbid disease (eg chronic renal failure or cancer)

Here Keith Oldroyd presents the results of LEADERS-FREE and how this may change the way we treat high risk population who often have the most to gain from revascularisation.

 

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In